ID | 68952 |
FullText URL | |
Author |
Murata, Hitoshi
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
Ogawa, Kazuki
Tama Biochemical Co., Ltd.
Yasui, Yu
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Ochi, Toshiki
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Tomonobu, Nahoko
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Yamamoto, Ken-Ichi
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kinoshita, Rie
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
researchmap
Wada, Yoji
Tama Biochemical Co., Ltd.
Nakamura, Hiromichi
Tama Biochemical Co., Ltd.
Nishibori, Masahiro
Department of Translational Research and Drug Development, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Kaken ID
publons
researchmap
Sakaguchi, Masakiyo
Department of Cell Biology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
ORCID
Kaken ID
publons
researchmap
|
Abstract | Sterile alpha and Toll/interleukin receptor motif-containing protein 1 (SARM1) is a nicotinamide adenine dinucleotide (NAD+) hydrolase involved in axonal degeneration and neuronal cell death. SARM1 plays a pivotal role in triggering the neurodegenerative processes that underlie peripheral neuropathies, traumatic brain injury, and neurodegenerative diseases. Importantly, SARM1 knockdown or knockout prevents the degeneration; as a result, SARM1 has been attracting attention as a potent therapeutic target. In recent years, the development of several SARM1 inhibitors derived from synthetic chemical compounds has been reported; however, no dietary ingredients with SARM1 inhibitory activity have been identified. Therefore, we here focused on dietary ingredients and found that carnosol, an antioxidant contained in rosemary, inhibits the NAD+-cleavage activity of SARM1. Purified carnosol inhibited the enzymatic activity of SARM1 and suppressed neurite degeneration and cell death induced by the anti-cancer medicine vincristine (VCR). Carnosol also inhibited VCR-induced hyperalgesia symptoms, suppressed the loss of intra-epidermal nerve fibers in vivo, and reduced the blood fluid level of phosphorylated neurofilament-H caused by an axonal degeneration event. These results indicate that carnosol has a neuroprotective effect via SARM1 inhibition in addition to its previously known antioxidant effect via NF-E2-related factor 2 and thus suppresses neurotoxin-induced peripheral neuropathy.
|
Keywords | SARM1
carnosol
NAD+
axon degeneration
peripheral neuropathy
|
Published Date | 2025-06-30
|
Publication Title |
Antioxidants
|
Volume | volume14
|
Issue | issue7
|
Publisher | MDPI AG
|
Start Page | 808
|
ISSN | 2076-3921
|
Content Type |
Journal Article
|
language |
English
|
OAI-PMH Set |
岡山大学
|
Copyright Holders | © 2025 by the authors.
|
File Version | publisher
|
DOI | |
Related Url | isVersionOf https://doi.org/10.3390/antiox14070808
|
License | https://creativecommons.org/licenses/by/4.0/
|
Citation | Murata, H.; Ogawa, K.; Yasui, Y.; Ochi, T.; Tomonobu, N.; Yamamoto, K.-I.; Kinoshita, R.; Wada, Y.; Nakamura, H.; Nishibori, M.; et al. Carnosol, a Rosemary Ingredient Discovered in a Screen for Inhibitors of SARM1-NAD+ Cleavage Activity, Ameliorates Symptoms of Peripheral Neuropathy. Antioxidants 2025, 14, 808. https://doi.org/10.3390/antiox14070808
|
助成情報 |
22K06884:
軸索変性誘導分子SARM1の活性・分解制御によるパーキンソン病治療法の開発
( 独立行政法人日本学術振興会 / Japan Society for the Promotion of Science )
24R8:
( 公益財団法人岡山医学振興会 / Okayama Medical Foundation )
|